A Prospective Clinical Trial to Evaluate Xcell Amnio MatrixTM (XAM) in Managing Chronic Non-healing DFUs
108
about 1 year
18+
3 sites in CA, TX
Why this study is shown
What this study is about
This trial is testing whether applying Xcell Amnio MatrixTM (XAM) as an adjunct to standard care helps heal chronic non-healing diabetic foot ulcers. Participants will receive XAM weekly for 12 weeks and be followed up after treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Xcell Amnio Matrix
- 2.Take Standard of Care (SOC)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change in pain in the target ulcer assessed using the Numerical Pain Rating Scale (NPRS) during the 12 weeks of the Treatment Phase.